|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Highly efficient resolutions with isopropylidene glycerol 3- carboxy-2-naphthoate 显示文摘 | Pallavicini M Bolchi C Furnagalli L | 2002 | Tetrahedron: Asymmetry2002，13，： | 1 |
| 2 | Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display 显示文摘 | Mullaney B Pallavicini M Marks J | 2001 | Infect Immun2001，69，： | 1 |
| 3 | Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells,inhibits growth,and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo显示文摘 | Park CC Zhang H Pallavicini M | 2006 | Cancer Res2006，66，3： | 1 |
| 4 | β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cuheres and in vivo 显示文摘 | Park CC Zhang H Pallavicini M Gray JW Baehner F Park CJ | 2006 | Cancer Res2006，66，1： | 1 |
| 5 | FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle显示文摘 | Faulkner G Pallavicini A Comelli A Salamon M Bortoletto G Ievolella C | 2000 | J Biol Chem2000，275，41： | 1 |
| 6 | Resolution of 2-substituted 1,4-benzodioxanes by entrainment 显示文摘 | Bolchi C Pallavicini M FumagaUi L | 2007 | Tetrahedron: Asymmetry2007，18，9： | 1 |
| 7 | The salmonid cathelicidins: a gene family with highly varied C-terminal antimicrobial domains显示文摘 | Scocchi M Pallavicini A Salgaro R | 2009 | Comp Biochem Physiol B Biochem Mol Biol2009，152，4： | 1 |
| 8 | Betal integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo显示文摘 | Park CC Zhang H Pallavicini M | 2006 | Cancer Res2006，66，3： | 1 |
| 9 | Betal integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo显示文摘 | Park CC Zhang H Pallavicini M | 2006 | Cancer Res2006，66，： | 1 |
| 10 | Specific immunofluorime-tric assay detecting the Chemotactic epitope of the urokinase recep-tor(uPAR) 显示文摘 | Hesnati M Pallavicini I Daverio K | 2006 | J Immunol Methods2006，308，12： | 1 |
| 11 | Microbial biodiversity of the liquid fraction of rumen content from lactating cows 显示文摘 | SANDRI M MANFRIN C PALLAVICINI A | 2014 | Animal2014，8，04： | 1 |
| 12 | Resolution of 2- substituted 1,4-benzodloxanes by entrainment 显示文摘 | Bolchi C Pallavicini M FumagaUi L | 2007 | Tetrahedron Asymmetry2007，18，9： | 1 |
| 13 | Topical role and future perspectives of sonographic contrast agents in the differential diagnosis of solid thyroid lesions 显示文摘 | Calliada F Pallavicini D Pasamonti M | 2000 | Rays2000，25，2： | 1 |
| 14 | AG-013736, a novel inhibitor of VEGF receptor tyrosine kina- ses,inhibits breast cancer growth and decreases vascular per- meability as detected by dynamic contrast-enhanced magnetic resonance imaging显示文摘 | Wilmes L J Pallavicini M G Fleming L M | 2007 | Magn Reson Imaging2007，25，3： | 1 |
| 15 | A Zinc ( Ⅱ )-driven intramolmalar photoinduced, electron tmnsfe显示文摘 | FABBRIZZI L LICCHELLI M PALLAVICINI P | 1996 | Inorganic Chemistry1996，35，： | 1 |
| 16 | Highly efficient raeemisation of a key intermediate of the antibi- otic moxifloxacin 显示文摘 | PALLAVICINI M BOLCHI C VALOTI E | 2011 | Tetrahedron : Asymmetry2011，22，4： | 1 |
| 17 | Topical role and future perspectives of sonographic contrast agenls in the differential diag- nosis of solid thyroid lesions显示文摘 | Galliada F Pallavicini D Pasamonti M | 2000 | Rays2000，25，2： | 1 |
| 18 | 查看详情显示文摘 | Freddi S Sironi L D'Antuono R Morone D Don伽A Cabrini E D'Alfonso L Collini M Pallavicini P Baldi G Mag-gioni D Chirico G | | 0，，5： | 1 |
| 19 | Flow cytometric measurement of total DNA content and incorpo- rated bromodeoxyuridine显示文摘 | Dolbeare F Gratzner H Pallavicini M G | 1983 | Proc Natl Acad Sci U S A1983，80，18： | 1 |
| 20 | Resolution of o-and m-substituted 1-phenylethylamines with isopropylidene glycerol hydrogen phthalate显示文摘 | M Pallavicini | 2001 | Tetrahedron:Asymmetry2001，12，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员